438 related articles for article (PubMed ID: 26555265)
1. Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.
Marty-Roix R; Vladimer GI; Pouliot K; Weng D; Buglione-Corbett R; West K; MacMicking JD; Chee JD; Wang S; Lu S; Lien E
J Biol Chem; 2016 Jan; 291(3):1123-36. PubMed ID: 26555265
[TBL] [Abstract][Full Text] [Related]
2. Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review.
Lacaille-Dubois MA
Phytomedicine; 2019 Jul; 60():152905. PubMed ID: 31182297
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.
Wilson NS; Duewell P; Yang B; Li Y; Marsters S; Koernig S; Latz E; Maraskovsky E; Morelli AB; Schnurr M; Ashkenazi A
J Immunol; 2014 Apr; 192(7):3259-68. PubMed ID: 24610009
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages.
Son S; Hwang I; Han SH; Shin JS; Shin OS; Yu JW
J Biol Chem; 2017 Dec; 292(50):20437-20448. PubMed ID: 29051224
[TBL] [Abstract][Full Text] [Related]
5. The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1.
Moore A; McCarthy L; Mills KH
Vaccine; 1999 Jun; 17(20-21):2517-27. PubMed ID: 10418898
[TBL] [Abstract][Full Text] [Related]
6. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
Embry CA; Franchi L; Nuñez G; Mitchell TC
Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ribosomal function triggers innate immune signaling through activation of the NLRP3 inflammasome.
Vyleta ML; Wong J; Magun BE
PLoS One; 2012; 7(5):e36044. PubMed ID: 22606244
[TBL] [Abstract][Full Text] [Related]
9. Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function.
Guey B; Bodnar M; Manié SN; Tardivel A; Petrilli V
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17254-9. PubMed ID: 25404286
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
11. The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome.
Schweneker K; Gorka O; Schweneker M; Poeck H; Tschopp J; Peschel C; Ruland J; Gross O
Immunobiology; 2013 Apr; 218(4):664-73. PubMed ID: 22921586
[TBL] [Abstract][Full Text] [Related]
12. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
13. Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome.
Darisipudi MN; Allam R; Rupanagudi KV; Anders HJ
PLoS One; 2011; 6(5):e19588. PubMed ID: 21625424
[TBL] [Abstract][Full Text] [Related]
14. GPRC6A mediates Alum-induced Nlrp3 inflammasome activation but limits Th2 type antibody responses.
Quandt D; Rothe K; Baerwald C; Rossol M
Sci Rep; 2015 Nov; 5():16719. PubMed ID: 26602597
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages.
Itoh R; Murakami I; Chou B; Ishii K; Soejima T; Suzuki T; Hiromatsu K
Biochem Biophys Res Commun; 2014 Sep; 452(3):689-94. PubMed ID: 25193701
[TBL] [Abstract][Full Text] [Related]
16. CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01.
Bosteels C; Fierens K; De Prijck S; Van Moorleghem J; Vanheerswynghels M; De Wolf C; Chalon A; Collignon C; Hammad H; Didierlaurent AM; Lambrecht BN
Front Immunol; 2020; 11():606805. PubMed ID: 33519816
[TBL] [Abstract][Full Text] [Related]
17. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
Demento SL; Eisenbarth SC; Foellmer HG; Platt C; Caplan MJ; Mark Saltzman W; Mellman I; Ledizet M; Fikrig E; Flavell RA; Fahmy TM
Vaccine; 2009 May; 27(23):3013-21. PubMed ID: 19428913
[TBL] [Abstract][Full Text] [Related]
18. Activation of the NLRP3 Inflammasome by Particles from the Echinococcus granulosus Laminated Layer.
Casaravilla C; Pittini Á; Rückerl D; Allen JE; Díaz Á
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32571988
[TBL] [Abstract][Full Text] [Related]
19. The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1β Secretion.
Moriyama M; Chen IY; Kawaguchi A; Koshiba T; Nagata K; Takeyama H; Hasegawa H; Ichinohe T
J Virol; 2016 Apr; 90(8):4105-4114. PubMed ID: 26865721
[TBL] [Abstract][Full Text] [Related]
20. Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2.
Traba J; Geiger SS; Kwarteng-Siaw M; Han K; Ra OH; Siegel RM; Gius D; Sack MN
J Biol Chem; 2017 Jul; 292(29):12153-12164. PubMed ID: 28584055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
